New drug discovery company secures GBP2.4m series-A funding to tackle chronic respiratory disease
Enterprise Therapeutics, a drug discovery company focused on new therapeutics for respiratory diseases, has secured an additional GBP2.4m (USD3.6m) in Series-A financing. The funds are comprised of GBP2m by new investor, Imperial Innovations and GBP0.4m increase by founding investor Epidarex Capital, bringing the total Series-A round to GBP4m. The



